Consensus EPS · Q2 2026
-$0.96
Consensus revenue · Q2 2026
$0
Analysts
4
Expected report
Aug 12, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 4 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| EPS | -$0.99 | -$0.96 | -$0.92 |
| EBITDA | $0 | $0 | $0 |
| EBIT | $0 | $0 | $0 |
| Net income | -$60.5M | -$59.3M | -$58.1M |
- Revenue$0
- EPS-$0.96
- EBITDA$0
- EBIT$0
- Net income-$59.3M
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| EPS | -$0.96 | -$0.96 | — | — | 0% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Kodiak Sciences (KOD) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $56.00
- Consensus
- $63.75
- Median
- $59.50
- High
- $80.00
- Current
- $41.58
- Upside
- +53.3%
Upside calculated vs most recent trading price of $41.58.
Consensus across all covering analysts. See the ranking ›
Analyst ratings
Consensus: Buy — based on 18 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 11, 2026 | Chardan Capital | upgrade | Neutral | Buy |
| Mar 27, 2026 | UBS | maintain | Buy | Buy |
| Mar 27, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 22, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 17, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 17, 2025 | Chardan Capital | maintain | Neutral | Neutral |
| Nov 11, 2025 | HC Wainwright & Co. | upgrade | Neutral | Buy |
| Oct 24, 2025 | JP Morgan | upgrade | Neutral | Overweight |
| Oct 6, 2025 | Chardan Capital | maintain | Neutral | Neutral |
- May 11, 2026Chardan CapitalBuy
- Mar 27, 2026UBSBuy
- Mar 27, 2026HC Wainwright & Co.Buy
- Feb 10, 2026HC Wainwright & Co.Buy
- Jan 22, 2026HC Wainwright & Co.Buy
- Nov 17, 2025HC Wainwright & Co.Buy
- Nov 17, 2025Chardan CapitalNeutral
- Nov 11, 2025HC Wainwright & Co.Buy
- Oct 24, 2025JP MorganOverweight
- Oct 6, 2025Chardan CapitalNeutral
Frequently asked questions
Kodiak Sciences (KOD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.